Does startup equity pay out in an acquisition?

What happened when Foursquare was acquired?

Foursquare was acquired by the advertising company Infillion in September 2026, and the deal returned nothing to shareholders. Co-founder Dennis Crowley laid it out in a public essay in late October 2026: "$0 for preferred, $0 for common." He described finding the news buried around page 50 of the sale paperwork, in a single sentence saying the preferred stock had been cancelled and extinguished. The purchase price was never disclosed. The company had raised roughly $411 million across 17 years, was valued near $600 million at its peak, posted consecutive years above $100 million in revenue after pivoting to enterprise location data, and shut its consumer app in 2024. Crowley apologized to about 1,600 former employees for an ending that made their collective work look worth nothing.

Read that sequence again, because it demolishes the story most candidates tell themselves about equity. This wasn't a flameout. The product had real revenue, a recognizable brand, data big advertisers paid for, and a buyer who wanted it enough to keep the name. None of that saved the shareholders. A company can be genuinely valuable and still be worth zero to the people holding common stock, because what you own isn't a slice of the business — it's a claim that sits last in line behind everyone who wrote a check before you.

That's the bridge to your job search. If you're weighing an offer with a big grant and a below-market salary, Foursquare is the case study to keep on your desk. The question isn't whether the company will succeed; it's whether the specific exit you're betting on clears the capital that's already stacked above you. The same logic applies to an equity-heavy offer when the exit keeps sliding — time and the preference stack both work against common stock, and neither shows up in the headline number a recruiter quotes you.

Why can an acquisition pay common shareholders zero?

An acquisition pays common shareholders zero whenever the sale price doesn't clear the liquidation preference stack. Every preferred round gets its money back first — usually 1x the amount invested — and any debt sits ahead of that. Common stock, which is what your options and RSUs turn into, splits whatever remains. If a few hundred million went in and the business sells for less than what's owed above you, there is nothing left to split. That's not a scandal or a betrayal; it's the arithmetic written into the documents on day one. Plain 1x non-participating terms appear in roughly 96% of recent venture financings, so the problem usually isn't predatory deal terms. It's the size of the stack relative to the price.

Structure makes it worse in specific, identifiable ways. Participating preferred takes its 1x and then shares in the leftovers, shrinking common's slice twice. Multiples above 1x — rare, but they show up in rescue rounds and structured late-stage deals — can swallow the entire price. Seniority matters too: later rounds often get paid before earlier ones, so a big Series E can wipe out the Series A long before it reaches you. Venture debt and convertible notes rank ahead of all of it. Add a retention pool carved out for key staff at closing, and the residual that reaches common can be a rounding error even in a deal that looks respectable from outside.

There's a quieter way employees end up with nothing, and it has nothing to do with the preference stack. Vested options are a right to buy, not ownership. Leave the company and you typically get 90 days to exercise — about 82% of companies still use that window — and if you can't fund the strike price plus the tax bill inside three months, the shares vanish back into the pool. Thousands of people reach an exit having already forfeited the equity they earned. The deal paperwork never mentions them, because by then they weren't shareholders at all.

Which four equity terms should you ask about before signing?

Ask about four things, in this order: the preference stack, your strike price against the current valuation, the vesting schedule plus the post-termination exercise window, and whether unvested equity accelerates in a change of control. Those four determine almost everything about whether a grant can pay. A recruiter who can answer all four quickly is working at a company that treats equity as real compensation. One who deflects with "the upside is huge" is quoting you a lottery ticket and calling it salary. You're allowed to ask before you sign, and the asking itself is diagnostic — the reaction tells you as much as the answer does.

On the stack, ask how much preferred capital and debt sits ahead of common, and whether any of it is participating or carries a multiple. You may get a range rather than a number; a range is fine, silence isn't. On strike price, ask for your strike, the latest 409A valuation, and the price of the most recent preferred round. If your strike is close to the last preferred price, your options only pay on a genuinely great exit. A live secondary market helps here, since what a tender offer price says about your shares is a far more honest signal than a headline valuation from two years ago.

On vesting, get the schedule, the cliff, and the exercise window in writing, then ask whether the window can be extended beyond 90 days — plenty of companies will do it for a specific hire, and almost none offer it unprompted. On acceleration, ask whether the plan provides double-trigger treatment: equity accelerates if the company is acquired and you're terminated without cause. Double-trigger is the standard that venture-backed boards actually adopt, so asking for it isn't aggressive. Watch for one trap even good answers hide: if the buyer cancels or cashes out unvested equity at closing, there's nothing left for a later trigger to accelerate.

How do you price equity against base salary in an offer?

Price the equity at a steep discount to its stated value, then negotiate base salary as if the grant might be zero. Here's my contrarian position, and I'll defend it: for a private-company offer where you can't see the preference stack, assign the equity an expected value of zero in your decision math. Not because it will be zero — plenty of grants pay beautifully — but because an unknowable number shouldn't drive a decision you make once. Treat the grant as a bonus you'd be delighted to receive and would never plan around. That reframing changes how hard you push on cash, and pushing on cash is the only part of the package that's certain.

Run the numbers in dollars per year rather than headline totals. Say a company offers $150,000 plus a grant "worth $200,000" over four years, while the market rate for the role is $180,000. You're being asked to fund $30,000 a year — $120,000 over the vest — in exchange for a claim that pays only if the exit clears the stack and you stay long enough to vest. Then apply the base rates: most startups don't reach a large exit, and even in a recovering market where down rounds fell to 11.4% of priced rounds in early 2026, acquisitions still routinely land below the last private valuation.

Four questions tighten the estimate fast. What percentage of the company does my grant represent, on a fully diluted basis? What's the strike and the current 409A? What did the last round price at, and how much has been raised in total? Has the company done a secondary or tender at a known price? With those answers you can sketch a floor and a ceiling. Without them you're guessing, and a guess is exactly what you shouldn't pay $30,000 a year for. This is also where the mechanics of countering after the offer lands matter — the ask has to arrive with the numbers attached.

What do you say to move value from equity into salary?

Say the quiet part plainly and attach a number: you value the equity, you can't price it from outside, and you need the cash to reflect that uncertainty. Try this. "I'm genuinely excited about this, and I want the equity to be part of why I join. The honest issue is that I can't value it without knowing what sits ahead of common. So I'd like to close the gap on base — $180,000 works, and I'll take the grant as offered." That script works because it's not adversarial. You've given them a reason, a specific figure, and an easy yes.

When base won't move, go after the terms that cost the company nothing today. "If the band is capped at $165,000, could we extend the post-termination exercise window to five years? That costs you nothing now and makes the grant far more real to me." Or: "Can we put double-trigger acceleration in the offer letter?" Or ask for a signing bonus sized to the first-year gap, which lands on this year's budget rather than the salary band. Each of these is a legitimate trade, and there's a longer playbook for trading other benefits when base pay won't budge if the money is genuinely frozen.

One line to avoid: "I don't really believe in the equity." You'll read as a cynic rather than a careful buyer. Frame it as risk pricing, not doubt — hiring managers respect that distinction, because it's how they think about their own offers. And know that all of this leverage comes from having competing options, which starts well before the money conversation. If your applications aren't converting into offers you can play against each other, fix the document that gets you in the room: run your CV through a free analysis and see your score out of 100 and ATS compatibility before you send the next one.

Frequently asked questions